Urea

Urea

SCHEMBL15380856

NC(N)=O.c1ncc2cc[nH]c2n1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.49
CDK8 P49336 7/20 0.47
CDK7 P50613 2/20 0.47
CCNT1 O60563 1/20 0.47
CCND1 P24385 1/20 0.47
CCNC P24863 1/20 0.47
CDK9 P50750 1/20 0.47
CCNH P51946 1/20 0.47
MNAT1 P51948 1/20 0.47
CDK6 Q00534 1/20 0.47
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44
AXL P30530 2/20 0.41
NUDT1 P36639 1/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
MAPK1 P28482 1/20 0.41
PLK4 O00444 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetamide SCHEMBL9934069 0.93 RIPK1 (0.47) RIPK1CDK8CDK7CCNT1CCND1
SCHEMBL64925 0.90
SCHEMBL29407705 0.90
SCHEMBL2078432 0.90 AXL (0.48) RIPK1CDK8CDK7CCNT1CCND1
Hydrochloric Acid SCHEMBL310786 0.88 AXL (0.47) RIPK1CDK8CDK7CCNT1CCND1
Hydrochloric Acid SCHEMBL31308615 0.88 AXL (0.47) RIPK1CDK8CDK7CCNT1CCND1
Hydrochloric Acid SCHEMBL311520 0.88 AXL (0.47) RIPK1CDK8CDK7CCNT1CCND1
SCHEMBL7500296 0.88 AXL (0.47) RIPK1CDK8CDK7CCNT1CCND1
SCHEMBL3845938 0.88 AXL (0.47) RIPK1CDK8CDK7CCNT1CCND1
SCHEMBL15880172 0.87 AXL (0.42) RIPK1CDK8CDK7CCNT1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130303563-A1 TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2013-11-14 US claimed
EP-3600440-A1 REDUCED EXPOSURE CONJUGATES MODULATING THERAPEUTIC TARGETS Sienna Biopharmaceuticals, Inc. (US) 2020-02-05 EP disclosed
WO-2020023389-A1 REDUCED EXPOSURE COMPOSITIONS MODULATING THERAPEUTIC TARGETS SIENNA BIOPHARMACEUTICALS, INC. (US) 2020-01-30 WO disclosed
WO-2018175315-A1 POLYMER CONJUGATES OF STAUROSPORINE DERIVATIVES HAVING REDUCED EXPOSURE SIENNA BIOPHARMACEUTICALS, INC. (US) 2018-09-27 WO disclosed
WO-2018175340-A1 REDUCED EXPOSURE CONJUGATES MODULATING THERAPEUTIC TARGETS SIENNA BIOPHARMACEUTICALS, INC. (US) 2018-09-27 WO disclosed
US-9198900-B2 Treatment of peritoneal injury using JAK inhibitors LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2015-12-01 US disclosed
US-20130303563-A1 TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER 2013-11-14 US disclosed
CN-102822177-A Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors PFIZER 2012-12-12 CN disclosed
CN-102822177-A Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors PFIZER 2012-12-12 CN disclosed